GUJARAT INJECT (KERALA) LTD. - 524238 - Announcement under Regulation 30 (LODR)-Issue of Securities
Approved Issue of Up To 10000000 Warrants each convertible into or exchangeable for, 1 (one) fully paid-up equity share of the company of Face Value of Rs. 10/- each to the proposed allottes, on a preferential basis (''''Preferential Issue'''') GUJARAT INJECT (KERALA) LTD. - 524238 - Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. Saturday, December 16, 2023
1. Proposed approval of shareholders for increase in the Authorized Share Capital of the Company 2. Approved issue of up to 10000000 warrants each convertible into or exchangeable for, 1 (one) fully paidup equity share of the Company of face value of Rs. 10/- each to the proposed allottees, on a preferential basis ('Preferential Issue') 3. Approved alteration in Memorandum of Association of the Company in line with the Companies Act, 2013 and addition of Object related to Agriculture Products 4. Approved adoption of new set of Articles of Association of the Company in line with the Companies Act, 2013; 5. Appointed National Securities Depository Limited (NSDL) as Remote E-Voting Agency for resolutions proposed to be passed at Extra Ordinary General Meeting. GUJARAT INJECT (KERALA) LTD. - 524238 - Closure of Trading Window
Trading Window for dealing in Equity Shares of company by he insiders covered under Company''s code of internal procedure and conduct for prevention of insider trading in securities has been closed from December 13, 2023 and shall remain closed till 48 hours after the declaration and publication of outcome of Board Meeting to be held on Saturday, December 16, 2023. GUJARAT INJECT (KERALA) LTD. - 524238 - Board Meeting Intimation for Intimation Of Issuance Of Securities On Preferential Basis
GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/12/2023 ,inter alia, to consider and approve the issuance of securities of Preferential Basis and any other items of businesses as the Board may think fit. In this connection, in accordance with BSE Circular no. LIST /COMP/01/2019 20 dated April 2, 2019 - Clarification regarding trading restriction period and the Securities and Exchange Board of India (Prohibition of Insider Trading) (Second Amendment) Regulations, 2019, the trading window for dealing in Equity Shares of the Company by the Insiders covered under Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities has been closed from December 13, 2023 and shall remain closed till 48 hours after the declaration and publication of Outcome of Board Meeting to be held on Saturday, December 16, 2023. Kindly take the same on your record and oblige us. GUJARAT INJECT (KERALA) LTD. - 524238 - Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. Wednesday, November 22, 2023 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on Wednesday, November 22, 2023 at the Administrative Office of the Company which was commenced at 03:30 P.M. and concluded at 04:15 P.M. have inter alia: 1) To took note of the withdrawal of proposal for raising funds by way of acceptance of unsecured Loans with an option of conversion into equity shares of Gujarat Inject Kerala Limited, subject to obtaining requisite approval of the shareholders of the Company. There is no other business to be transacted apart from this. GUJARAT INJECT (KERALA) LTD. - 524238 - Closure of Trading Window
The trading window for dealing in Equity shares of the Company by the Insiders covered under Company''s code of Internal procedures and conduct for prevention of Insider trading in securities has already been closed 17/11/2023 and shall remain closed till 48 hours after declaration and publication of outcome of Board meeting to be held on 22/11/2023 GUJARAT INJECT (KERALA) LTD. - 524238 - Board Meeting Intimation for Board Meeting Scheduled To Be Held On 22/11/2023
GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/11/2023 ,inter alia, to consider and approve 1) acceptance of unsecured Loans with an option of conversion into equity shares of Gujarat Inject Kerala Limited, subject to obtaining requisite approval of the shareholders of the Company; 2) an increasing borrowing limits in excess of the limit specified under section 180(1)(c) of Companies Act, 2013, subject to obtaining requisite approval of the shareholders of the Company and 3) Any other items of business GUJARAT INJECT (KERALA) LTD. - 524238 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On November 6, 2023
In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on November 6, 2023 at the Administrative Office of the Company which was commenced at 05:30 P.M. and concluded at 06:15 P.M. have inter alia 1) considered, approved and taken on record the unaudited Standalone Financial Results of the Company for the quarter ended on September 30, 2023 along with Limited review Report. In this regards, we are hereby submitting the followings: a) unaudited (Standalone) Financial Results for the quarter ended on September 30, 2023 and b) Limited review report; 2) to took note of the withdrawal of proposal for raising funds by way of issue of one or more instruments including equity shares, convertible securities of any description or warrants or debt securities, through preferential issue, private placements, rights issue or any other methods or combination thereof. GUJARAT INJECT (KERALA) LTD. - 524238 - Quarterly Result For Quarter Ended On September 30, 2023.
Quarterly Result for Quarter ended on September 30, 2023. GUJARAT INJECT (KERALA) LTD. - 524238 - Board Meeting Intimation for Intimation For Board Meeting Re-Scheduled On Monday, November 6, 2023
GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 ,inter alia, to consider and approve To consider, approve & take on record the Unaudited Financial Result for the quarter ended on September 30, 2023 as per Regulation 33 of the Listing Regulation, 2) To consider the proposal for raising funds by way of issue of one or more instruments including equity shares, convertible securities of any description or warrants or debt securities, through preferential issue, private placements, rights issue or any other methods or combination thereof as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required, including the approval of the shareholders of the Company, and 3) Any other items as may be decided by the Board of Directors. The closure of trading window as intimated to stock exchange earlier will continue till 48 hours from the conclusion of Board Meeting.